Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040 ☆
Titel:
Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040 ☆
Auteur:
El-Khoueiry, A.B. Trojan, J. Meyer, T. Yau, T. Melero, I. Kudo, M. Hsu, C. Kim, T.-Y. Choo, S.-P. Kang, Y.-K. Yeo, W. Chopra, A. Soleymani, S. Yao, J. Neely, J. Tschaika, M. Welling, T.H. Sangro, B.